What is POTS and why is it more common now?
The condition affecting young women
![Heart balloon with stethoscope.](https://cdn.mos.cms.futurecdn.net/FqkbYfsLkDnorc5Jy7Kbs9-415-80.jpg)
Cases of postural orthostatic tachycardia syndrome (POTS) have increased since the pandemic. The condition is mostly found in women and can be debilitating, affecting people who were seemingly healthy before. It can be exacerbated by a viral infection like Covid-19 and does not have a cure.
What is POTS?
POTS is a "condition that causes a number of symptoms when you transition from lying down to standing up, such as a fast heart rate, dizziness and fatigue," said the Cleveland Clinic. "If you have POTS, your body can't coordinate the balancing act of blood vessel constriction (squeezing) and heart rate response," which means that "your body can't keep your blood pressure steady and stable." The condition affected between one and three million people prior to 2020. Now, research suggests that anywhere from 2% to 14% of people who are infected by Covid-19 may develop POTS. "The most common trigger of POTS is a viral infection," Svetlana Blitshteyn, a neurologist and the director of the Dysautonomia Clinic in Buffalo, New York, said to CBS News. "This includes viruses like influenza and parvovirus and Covid-19."
There has been a recent slew of diagnoses in teens and adults who were otherwise healthy. Specifically, highly-trained female athletes have been affected. "These patients are young people in their 20s, 30s and 40s who were healthy or had minor medical problems that didn't impact their lives before and now they are expressing extreme fatigue, dizziness, headache, inability to exercise and some are unable to work," Blitshteyn said. However, doctors are not quick to diagnose POTS. "Since POTS isn't technically life-threatening, if you're fatigued or fainting, have a racing heartbeat, a doc will likely scan you for other, perhaps more immediately dangerous, things before considering POTS," said Self.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Who is most affected?
POTS is largely found in women, but "it's not a lock-and-key situation with just anybody getting Covid and then POTS," Camden Hebson, a pediatric cardiologist, said to The Washington Post. "It's that some patients had a predisposition to POTS to begin with, and then something comes along — it could be mono or covid or something else to give them a push." Women are also thought to be "more vulnerable to inflammation," said the Post. "It could reflect the damage that comes with being hit with a virus unknown to humans until 2020. And the stress associated with repetitive physical exhaustion could leave athletes at risk."
Athletes may be predisposed to the condition. Some of those diagnosed also had hypermobility, meaning they have a greater-than-average range of motion, which is beneficial in a number of sports. But hypermobility could also be making blood vessels "more stretchy," impacting heart rate and blood pressure, Sara Gould, an orthopedic surgeon, said to the Post. In addition, some POTS patients also have a "condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterized by post-exertional malaise (PEM) — a situation in which symptoms worsen after exercise," said National Geographic.
POTS has no cure, but steps can be taken to reduce symptoms, including exercise, diet changes, sleep changes, and in some cases, medication. "While POTS isn't life-threatening, it can greatly interfere with daily living and tasks," said Cleveland Clinic. "The good news is that a variety of treatments and strategies can help improve symptoms."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Today's political cartoons - September 7, 2024
Cartoons Saturday's cartoons - football widows, meddling kids, and more
By The Week US Published
-
Smoking ban: the return of the nanny state?
Talking Point Starmer's plan to revive Sunak-era war on tobacco has struck an unsettling chord even with some non-smokers
By The Week UK Published
-
Crossword: September 7, 2024
The Week's daily crossword puzzle
By The Week Staff Published
-
More women opt for home births despite high costs
Under the radar Wary of possible mistreatment by medical professionals, some women are bearing the out-of-pocket costs for a better option
By Theara Coleman, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Scottish drug deaths: what's gone wrong?
The Explainer The latest figures show an increase in drug misuse deaths in Scotland
By Richard Windsor, The Week UK Published
-
The battle for abortion buffer zones
The Explainer A 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'
By Harriet Marsden, The Week UK Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
Gender bias in medical research: how women are still overlooked
In depth Clinical trials have historically been male-centric, but they are leaving the medical community in the dark about women and girls
By Theara Coleman, The Week US Published
-
Can dementia be defeated?
Today's Big Question A new report identifies 14 risk factors
By Joel Mathis, The Week US Published
-
Deadly 'brain-eating' amoebas could be spreading thanks to climate change
Under the Radar Naegleria fowleri causes rare and lethal infection, but recent uptick in cases suggests it is thriving in warming waters
By Harriet Marsden, The Week UK Last updated